echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hasanlian Omeprazole Sodium for Injection passed the consistency evaluation

    Hasanlian Omeprazole Sodium for Injection passed the consistency evaluation

    • Last Update: 2022-01-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the evening of January 5, Harbin Sanlian issued an announcement saying that the company has recently received the approval notice for supplementary drug application approved and issued by the State Drug Administration, and omeprazole sodium for injection has passed the quality and efficacy consistency evaluation of generic drugs


    Omeprazole sodium for injection is mainly suitable for peptic ulcer bleeding, anastomotic ulcer bleeding; acute gastric mucosal damage complicated by stress state, acute gastric mucosal damage caused by non-steroidal anti-inflammatory drugs; prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.